Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q416975> ?p ?o }
Showing triples 1 to 63 of
63
with 100 triples per page.
- Q416975 subject Q6814466.
- Q416975 subject Q7007416.
- Q416975 subject Q7310239.
- Q416975 subject Q8358946.
- Q416975 subject Q8533683.
- Q416975 subject Q8843557.
- Q416975 abstract "Dacarbazine (brand names DTIC, DTIC-Dome; also known as DIC or imidazole carboxamide) is an antineoplastic chemotherapy drug used in the treatment of various cancers, among them malignant melanoma, Hodgkin lymphoma, sarcoma, and islet cell carcinoma of the pancreas. Dacarbazine is a member of the class of alkylating agents, which destroy cancer cells by adding an alkyl group (CnH2n+1) to its DNA. Dacarbazine is normally administered by intravenous infusion (IV) under the immediate supervision of a doctor or nurse. Dacarbazine is bioactivated in liver by demethylation to "MTIC" and then to diazomethane, which is an alkylating agent.It is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system.".
- Q416975 atcPrefix "L01".
- Q416975 atcSuffix "AX04".
- Q416975 casNumber "4342-03-4".
- Q416975 chEBI "4305".
- Q416975 drugbank "DB00851".
- Q416975 fdaUniiCode "7GR28W0FJI".
- Q416975 iupacName "5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide".
- Q416975 pubchem "2942".
- Q416975 thumbnail Dacarbazine_Formula_V.1.svg?width=300.
- Q416975 wikiPageExternalLink cancerweb.
- Q416975 wikiPageExternalLink oncolink.upenn.edu.
- Q416975 wikiPageExternalLink audit_page.jsp?_sourcePage=%2Fproduktfakta%2Fartikel_produkt.jsp&docType=7&nplId=19971212000080.
- Q416975 wikiPageExternalLink medline.
- Q416975 wikiPageWikiLink Q11000047.
- Q416975 wikiPageWikiLink Q127076.
- Q416975 wikiPageWikiLink Q152051.
- Q416975 wikiPageWikiLink Q180614.
- Q416975 wikiPageWikiLink Q181876.
- Q416975 wikiPageWikiLink Q209369.
- Q416975 wikiPageWikiLink Q223911.
- Q416975 wikiPageWikiLink Q287631.
- Q416975 wikiPageWikiLink Q335268.
- Q416975 wikiPageWikiLink Q37155.
- Q416975 wikiPageWikiLink Q413683.
- Q416975 wikiPageWikiLink Q419841.
- Q416975 wikiPageWikiLink Q5090632.
- Q416975 wikiPageWikiLink Q5867482.
- Q416975 wikiPageWikiLink Q6084258.
- Q416975 wikiPageWikiLink Q619908.
- Q416975 wikiPageWikiLink Q621834.
- Q416975 wikiPageWikiLink Q6814466.
- Q416975 wikiPageWikiLink Q7007416.
- Q416975 wikiPageWikiLink Q7075165.
- Q416975 wikiPageWikiLink Q7310239.
- Q416975 wikiPageWikiLink Q7430.
- Q416975 wikiPageWikiLink Q8358946.
- Q416975 wikiPageWikiLink Q8533683.
- Q416975 wikiPageWikiLink Q8843557.
- Q416975 wikiPageWikiLink Q974135.
- Q416975 atcPrefix "L01".
- Q416975 atcSuffix "AX04".
- Q416975 casNumber "4342-03-04".
- Q416975 chebi "4305".
- Q416975 drugbank "DB00851".
- Q416975 iupacName "5".
- Q416975 pubchem "2942".
- Q416975 unii "7".
- Q416975 type ChemicalSubstance.
- Q416975 type Drug.
- Q416975 type ChemicalObject.
- Q416975 type Thing.
- Q416975 type Q8386.
- Q416975 comment "Dacarbazine (brand names DTIC, DTIC-Dome; also known as DIC or imidazole carboxamide) is an antineoplastic chemotherapy drug used in the treatment of various cancers, among them malignant melanoma, Hodgkin lymphoma, sarcoma, and islet cell carcinoma of the pancreas. Dacarbazine is a member of the class of alkylating agents, which destroy cancer cells by adding an alkyl group (CnH2n+1) to its DNA.".
- Q416975 label "Dacarbazine".
- Q416975 seeAlso Q5867482.
- Q416975 depiction Dacarbazine_Formula_V.1.svg.